Search Results

The prefrontal cortex: a target for antipsychotic drugs

Author: Artigas, F.

Source: Acta Psychiatrica Scandinavica, Volume 121, Number 1, January 2010 , pp. 11-21(11)

Publisher: Blackwell Publishing

Editorial [Hot topic: The Search of Targets for Novel Antipsychotic Drugs (Executive Editor: Akihiro Takano)]

Author: Takano, Akihir

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 308-308(1)

Publisher: Bentham Science Publishers

The Application of PET Technique for the Development and Evaluation of Novel Antipsychotics

Author: Takano, Akihiro

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 371-377(7)

Publisher: Bentham Science Publishers

Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids

Authors: André, Véronique M.; Cepeda, Carlos; Cummings, Damian M.; Jocoy, Emily L.; Fisher, Yvette E.; William Yang, X.; Levine, Michael S.

Source: European Journal of Neuroscience, Volume 31, Number 1, January 2010 , pp. 14-28(15)

Publisher: Blackwell Publishing

Dopamine-oxytocin interactions in penile erection

Authors: Baskerville, T. A.; Allard, J.; Wayman, C.; Douglas, A. J.

Source: European Journal of Neuroscience, Volume 30, Number 11, December 2009 , pp. 2151-2164(14)

Publisher: Blackwell Publishing

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 302-314(13)

Publisher: Bentham Science Publishers

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 315-330(16)

Publisher: Bentham Science Publishers

Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism

Authors: Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih M.

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 10, November/December 2009 , pp. 1423-1434(12)

Publisher: Blackwell Publishing

Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic

Author: Citrome, L.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1762-1784(23)

Publisher: Blackwell Publishing

Signal Transduction via Cannabinoid Receptors

Authors: Dalton, George D.; Bass, Caroline E.; Van Horn, Cynthia G.; Howlett, Allyn C.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 422-431(10)

Publisher: Bentham Science Publishers

Translating 5-HT₄ receptor pharmacology

Author: sanger, g. j.

Source: Neurogastroenterology and Motility, Volume 21, Number 12, December 2009 , pp. 1235-1238(4)

Publisher: Blackwell Publishing

Theoretical Considerations on the Topological Organization of Receptor Mosaics

Authors: Agnati, Luigi F.; Fuxe, Kjell; Woods, Amina S.; Genedani, Susanna; Guidolin, Diego

Source: Current Protein and Peptide Science, Volume 10, Number 6, December 2009 , pp. 559-569(11)

Publisher: Bentham Science Publishers

Oral bioavailability and brain penetration of (−)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D₁ and antagonist at D₂ receptors, in rats

Authors: Sun, Yan; Dai, Jieyu; Hu, Zheyi; Du, Feifei; Niu, Wei; Wang, Fengqing; Liu, Fei; Jin, Guozhang; Li, Chuan

Source: British Journal of Pharmacology, Volume 158, Number 5, November 2009 , pp. 1302-1312(11)

Publisher: Blackwell Publishing

Role of type 3 deiodinase in cancer

Authors: Dentice, Monica; Ambrosio, Raffaele; Salvatore, Domenico

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 11, November 2009 , pp. 1363-1373(11)

Publisher: Informa Healthcare

Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice

Authors: Boeuf, Julien; Trigo, José Manuel; Moreau, Pierre-Henri; Lecourtier, Lucas; Vogel, Elise; Cassel, Jean-Cristophe; Mathis, Chantal; Klosen, Paul; Maldonado, Rafael; Simonin, Frédéric

Source: European Journal of Neuroscience, Volume 30, Number 5, September 2009 , pp. 860-868(9)

Publisher: Blackwell Publishing

Current therapy and drug pipeline for the treatment of patients with acromegaly

Authors: Kumar, Sampath; Ayuk, John; Murray, Robert

Source: Advances in Therapy, Volume 26, Number 4, April 2009 , pp. 383-403(21)

Publisher: Springer

Identification and characterization of a novel amphioxus dopamine D₁-like receptor

Authors: Burman, Chloe; Reale, Vincenzina; Srivastava, Deepak P.; Evans, Peter D.

Source: Journal of Neurochemistry, Volume 111, Number 1, October 2009 , pp. 26-36(11)

Publisher: Blackwell Publishing

Aripiprazole: Dose-Response Relationship in Schizophrenia and Schizoaffective Disorder

Authors: Mace, Shubhra; Taylor, David

Source: CNS Drugs, Volume 23, Number 9, 1 September 2009 , pp. 773-780(8)

Publisher: Adis International

Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT_2A Receptors

Authors: Vzquez-Borsetti, Pablo; Corts, Roser; Artigas, Francesc

Source: Cerebral Cortex, Volume 19, Number 7, 17 July 2009 , pp. 1678-1686(9)

Publisher: Oxford University Press

Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging

Authors: Howes, O. D.; Egerton, A.; Allan, V.; McGuire, P.; Stokes, P.; Kapur, S.

Source: Current Pharmaceutical Design, Volume 15, Number 22, August 2009 , pp. 2550-2559(10)

Publisher: Bentham Science Publishers